Concert pharmaceuticals Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Concert pharmaceuticals Contact Number

Contact Concert Pharmaceuticals

8 hours ago Concertpharma.com Show details

421 781.860

Contact Us Corporate Contacts Corporate Headquarters: Concert Pharmaceuticals, Inc. 65 Hayden Avenue, Suite 3000N Lexington, MA 02421 781.860.0045 Investor and Media Contact: [email protected] Business Development Contact: [email protected] General Inquiries: [email protected]

Category: Contact SupportShow more

Concert Pharmaceuticals, Inc. Company Profile Lexington

1 hours ago Dnb.com Show details

Find company research, competitor information, contact details & financial data for Concert Pharmaceuticals, Inc. of Lexington, MA. Get the latest business insights from Dun & Bradstreet.

Employees: 71
Total Assets: $159.26
Tangible Fixed Assets: $15.33
Location: 65 Hayden Ave Ste 3000N, Lexington, 02421-7994, MA

Category: Contact NumberShow more

Concert Pharmaceuticals

Just Now Concertpharma.com Show details

LATEST NEWS. Aug 05, 2021 Concert Pharmaceuticals Reports Second Quarter 2021 Financial Results. Jul 29, 2021 Concert Pharmaceuticals to Report Second Quarter 2021 Results on August 5, 2021

Category: Contact NumberShow more

Concert Pharmaceuticals Overview, News & Competitors

3 hours ago Zoominfo.com Show details

(781) 860-0045

Frequently Asked Questions regarding Concert Pharmaceuticals. Where are Concert Pharmaceuticals’s headquarters? Concert Pharmaceuticals’s headquarters are in 65 Hayden Ave, Ste 3000N, Lexington, Massachusetts, 02421, United States. What is Concert Pharmaceuticals’s phone number? Concert Pharmaceuticals’s phone number is (781) 860 …

Employees: 71
Phone: (781) 860-0045
Location: 65 Hayden Ave, Ste 3000N, Lexington, 02421, Massachusetts

Category: Contact NumberShow more

Concert Pharmaceuticals Crunchbase Company Profile & Funding

3 hours ago Crunchbase.com Show details

Contact Email [email protected] Phone Number 7816745322 Founded in April 2006, Concert Pharmaceuticals is a clinical stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium.

Founded: 2006
Founder: Richard Aldrich

Category: Contact NumberShow more

Investor FAQs Concert Pharmaceuticals

2 hours ago Ir.concertpharma.com Show details

Concert Pharmaceuticals, Inc. was incorporated in the State of Delaware on April 12, 2006. Where is Concert headquartered? Concert’s headquarters are located at 65 Hayden Avenue, Suite 3000N, Lexington, Massachusetts. The main office phone number is …

Category: Contact NumberShow more

Management Concert Pharmaceuticals

5 hours ago Concertpharma.com Show details

Ms. Virginia Braman joined Concert in April 2010 and currently serves as Vice President, Clinical Development. She has over 25 years of research, development and clinical experience. Prior to Concert, she had a variety of clinical roles across a number of therapeutic areas at Cambridge BioScience, ImmunoGen, Cardiokine, and NitroMed.

Category: Contact NumberShow more

Concert Pharmaceuticals, Inc. Email Format concertpharma

Just Now Rocketreach.co Show details

Concert Pharmaceuticals, Inc. uses 3 email formats, with first_initial last (ex. [email protected]) being used 96.9% of the time. Get Verified Emails for Concert Pharmaceuticals, Inc. Employees. Concert Pharmaceuticals, Inc.'s …

Category: Contact NumberShow more

Colleen Hamilton's email & phone Concert Pharmaceuticals

3 hours ago Rocketreach.co Show details

Sr Manager, Regulatory Affairs & Clinical Operations @ Concert Pharmaceuticals, Inc. Ra/QA Specialist @ Concert Pharmaceuticals, Inc. Regulatory & Clinical Specialist @ Concert Pharmaceuticals, Inc. Education: 2014 - 2016 Master Of Science in …

Category: Phone NumberShow more

Contact us – Avet Pharmaceuticals Inc.

4 hours ago Avetpharma.com Show details

(866) 901-1230

Our highly motivated team of experienced industry professionals are eager to work potential partners in order to find strategic solutions that maximize transaction value and profitability for both companies. If you are interested in pursuing a transaction with Avet please contact: [email protected] Toll free: (866) 901-1230.

Category: Contact SupportShow more

Let's Connect Amneal Pharmaceuticals

1 hours ago Amneal.com Show details

(877) 835-5472

Product Complaints & Adverse Events: Amneal and Impax Products (877) 835-5472, option 3. [email protected] . Administrative Offices: U.S. Corporate Offices

Category: Contact NumberShow more

Concert Pharmaceuticals, Inc. to Host Earnings Call

7 hours ago Finance.yahoo.com Show details

NEW YORK, NY / ACCESSWIRE / May 4, 2021 / Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 4, 2021

Category: Contact NumberShow more

Concert Pharmaceuticals Reports Second Quarter 2021

5 hours ago Ir.concertpharma.com Show details

(781) 674-5284

For additional information contact: Justine Koenigsberg (investors) Concert Pharmaceuticals, Inc. (781) 674-5284 [email protected] Kathryn Morris (media) The Yates Network (914) 204-6412 [email protected] . Source: Concert Pharmaceuticals, Inc.:

Category: Contact NumberShow more

Product Pipeline Concert Pharmaceuticals

4 hours ago Concertpharma.com Show details

Product Pipeline Our innovative approach has resulted in multiple drug candidates that offer improved ways to target a broad range of disease areas. Our lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. We are also assessing a number of earlier-stage pipeline candidates.

Category: Contact NumberShow more

Concert Pharmaceuticals Reports First Quarter 2021

4 hours ago Ir.concertpharma.com Show details

(781) 674-5284

For additional information contact: Justine E. Koenigsberg (Investors) Concert Pharmaceuticals, Inc. (781) 674-5284 [email protected] Kathryn Morris (media) The Yates Network (914) 204-6412 [email protected] . Source: Concert Pharmaceuticals, Inc.:

Category: Contact NumberShow more

Contact Us Konsyl – Konsyl Store

6 hours ago Konsyl.com Show details

410-822-5192

Please fill out the form, or email us at contact@konsyl.com and we will get back to you promptly. Konsyl Pharmaceuticals, Inc. 29515 Canvasback Drive, Suite B. Easton, MD 21601. Contact us directly at 1-410-822-5192. Monday - Friday, 8:30 AM - 5 PM EST.

Category: Contact SupportShow more

Current Openings Concert Pharmaceuticals

5 hours ago Concertpharma.com Show details

Current Openings We invite you to apply for any of our current openings. Please send your resume in the body text of an e-mail (no attachments, please) to: [email protected] Analytical Chemistry Quality Control Scientist II Principal Investigator, Chemical Development Scientist/Sr. Scientist, Chemical Development Concert provides equal employment …

Category: Contact NumberShow more

Concert Pharmaceuticals Announces Sale of VX561

7 hours ago Ir.concertpharma.com Show details

LEXINGTON, Mass.--(BUSINESS WIRE)--May 17, 2021-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) has purchased the potential future milestones under the companies’ 2017 asset purchase agreement relating to VX-561 (deutivacaftor) for $32 million. …

Category: Contact NumberShow more

Concert Pharmaceuticals Number of Employees 20122021

Just Now Macrotrends.net Show details

Concert Pharmaceuticals number of employees from 2012 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

CNCE Concert Pharmaceuticals Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the second quarter of 2021, on Thursday, August 5, 2021, before the U.S. financial markets open. The Company will host a conference call and webcast at 8:30 a.m. ET to discuss its second quarter 2021 financial results and provide a

Category: Contact NumberShow more

Concert Pharmaceuticals to Present at Upcoming Investor

8 hours ago Ir.concertpharma.com Show details

Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates. For more information please visit www.concertpharma.com or follow us on Twitter at @ConcertPharma or on LinkedIn.

Category: Contact NumberShow more

Concert Pharmaceuticals, inc (CNCE) Q2 2021 Earnings Call

8 hours ago Fool.com Show details

Concert Pharmaceuticals, inc (CNCE) Q2 2021 Earnings Call Transcript CNCE earnings call for the period ending June 30, 2021.

Category: Contact NumberShow more

Lara Burrows Baltimore City County, Maryland, United

8 hours ago Linkedin.com Show details

Concert Pharmaceuticals Reports Second Quarter 2021 Financial Results https://lnkd.in/dNU-UHZd #Alopeciaareata has been linked to a number of …

Connections: 316
Location: Baltimore City County, Maryland, United States

Category: Contact NumberShow more

Do Institutions Own Concert Pharmaceuticals, Inc. (NASDAQ

Just Now Finance.yahoo.com Show details

Hedge funds don't have many shares in Concert Pharmaceuticals. RA Capital Management, L.P. is currently the company's largest shareholder with 9.4% of …

Category: Contact NumberShow more

About Us – Nimbus

4 hours ago Nimbustx.com Show details

Investors. Nimbus Therapeutics is backed by world-class life science investors, including those listed below and others. The company closed a $24 million Series A financing in June 2011, a $43 million Series B financing in March 2015, an additional $65 million in financing in June 2018, $60 million in financing in October 2020, and $105 million in financing in July 2021.

Category: Contact NumberShow more

CONCERT PHARMACEUTICALS, INC. : CNCE Stock Price

6 hours ago Marketscreener.com Show details

83,1%. More Financials. Company. Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through the development of pharmaceutical products on its own behalf or in collaboration with others.

Category: Contact NumberShow more

Concert Pharmaceuticals Reports Second Quarter 2021

2 hours ago Finance.yahoo.com Show details

Concert Pharmaceuticals, Inc. Summary Balance Sheet Data (in thousands) (unaudited) June 30, 2021. December 31, 2020. Cash and cash equivalents $ 122,399 $ 77,202. Investments, available for sale

Category: Contact NumberShow more

Sandra Morales Stow, Massachusetts Professional

Just Now Linkedin.com Show details

Manager, Facility Operations. Amgen. Apr 2007 - May 20092 years 2 months. •Facilities and Operations site lead with direct oversight of facilities and logistics for Cambridge Site. 353,000 sq ft

Connections: 479
Location: Stow, Massachusetts

Category: Contact NumberShow more

Contact Us corporate Perrigo

4 hours ago Perrigo.com Show details

800-775-2054

Contact Padagis +1 800-775-2054. Find Padagis online: United States Israel. Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding PRIALT® (ziconitide intrathecal infusion), please contact Jazz Pharmaceuticals at +1 888 774 2581.

Category: Contact SupportShow more

Concert Pharmaceuticals : Landmarks and Bridges Will

9 hours ago Marketscreener.com Show details

In recognition of Alopecia Areata Awareness Month, bridges, buildings and other landmarks across the United States will be illuminated blue to raise awareness for this important autoimmune October 3, 2021

Category: Contact NumberShow more

James V. Cassella Net Worth, Biography & Insider Trading

1 hours ago Insidertrades.com Show details

(781) 860-0045

The corporate mailing address for Dr. Cassella and other Concert Pharmaceuticals executives is 65 HAYDEN AVENUE SUITE 3000N, LEXINGTON MA, 02421. Concert Pharmaceuticals can also be reached via phone at (781) 860-0045 and via email at [email protected]

Email: [email protected]
Phone: (781) 860-0045
Occupation: Insider, Concert Pharmaceuticals

Category: Contact NumberShow more

CONCERT PHARMACEUTICALS : TO PRESENT AT UPCOMING …

8 hours ago Marketscreener.com Show details

Concert's lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates. For more information please visit www.concertpharma.com or follow us on Twitter at @ConcertPharma or on LinkedIn. Contact:

Category: Contact NumberShow more

Concert Pharmaceuticals to Present at Upcoming Investor

5 hours ago Finance.yahoo.com Show details

Concert is also assessing a number of earlier-stage pipeline candidates. For more information please visit www.concertpharma.com or follow us on Twitter at @ConcertPharma or on LinkedIn .

Category: Contact NumberShow more

Marc A. Becker Net Worth, Biography & Insider Trading History

8 hours ago Insidertrades.com Show details

(781) 860-0045

The corporate mailing address for Mr. Becker and other Concert Pharmaceuticals executives is 65 HAYDEN AVENUE SUITE 3000N, LEXINGTON MA, 02421. Concert Pharmaceuticals can also be reached via phone at (781) 860-0045 and via email at [email protected]

Category: Contact NumberShow more

Concert Pharmaceuticals Market Cap 20122021 CNCE

1 hours ago Macrotrends.net Show details

Concert Pharmaceuticals market cap history and chart from 2012 to 2021. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number

Category: Contact NumberShow more

CNCE Stock Price Concert Pharmaceuticals Inc. Stock

8 hours ago Marketwatch.com Show details

CNCE Complete Concert Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Category: Contact NumberShow more

Richard Aldrich Co Founder & Partner @ Longwood Fund

9 hours ago Crunchbase.com Show details

Richard Aldrich is a co-founder of Concert Pharmaceuticals and has served as our Chairman of the Board since May 2006. Richard Aldrich co-founded Longwood Founders Fund in 2010, a fund that starts and invests in biotechnology companies, and currently serves as a Partner in the firm. biotech investment fund he founded in 2001.

Category: Contact NumberShow more

Samantha Burke Ph.D. Chemist Independent

1 hours ago Linkedin.com Show details

Independent Pharmaceutical Consultant. Jun 2013 - Present8 years 2 months. RTP, NC.

Title: Ph.D. Chemist at Independent …
Location: Cary, North Carolina, United States
Connections: 123

Category: Contact NumberShow more

PTAB Axes Hair Loss Treatment Patent In Incyte Law360

6 hours ago Law360.com Show details

The case is Incyte Corp. v. Concert Pharmaceuticals Inc., case number IPR2017-01256, at the Patent Trial and Appeal Board. --Editing by Stephen Berg. For a reprint of this article, please contact

Category: Contact NumberShow more

Statement of Changes in Beneficial Ownership (4)

6 hours ago Ih.advfn.com Show details

Nature of Indirect Beneficial Ownership (Instr. 4) This sale was effected pursuant to a Rule 10b5-1 trading plan entered into on March 23, 2021. These shares were sold to satisfy tax obligations associated with the vesting of restricted stock units. The price reported in Column 4 is a weighted average price.

Category: Contact NumberShow more

Speakers JAK Inhibitors Drug Development Running

9 hours ago Jak-drugdevelopment.com Show details

June 29-July 1, 2021 9.00am – 5.00pm EST 3.00pm- 11.00pm CEST Virtual Conference

Category: Contact NumberShow more

Ashley Prasse Miller Director Clinical Operations

7 hours ago Linkedin.com Show details

Ashley is a collaborative, highly-motivated, and innovative Clinical Operations Professional with >10 years experience in clinical strategy and end to end trial management (Phase I-IV) in

Title: Head of Clinical Operations at …
Location: Bend, Oregon, United States
1. 500+ connections

Category: Contact NumberShow more

John Court Principal Research Scientist Vertex

7 hours ago Linkedin.com Show details

“John started his pharma career in my group at Sterling Wintrhop. He was a key part of my team and his work pushed the elastase inhibitor project to the candidate stage. He was a …

Title: Principal Research Scale Up …
Location: Greater Boston
1. 500+ connections

Category: Contact NumberShow more

Robert Zelle VP & Senior Fellow, Drug Development

6 hours ago Crunchbase.com Show details

Number of Past Jobs 3 Robert Zelle is the VP & Senior Fellow, Drug Development at Concert Pharmaceuticals . Additionally, Robert Zelle has had 3 past jobs including Sr. Director, Regulatory Affairs & Product Development at Acusphere .

Category: Contact NumberShow more

Document SEC

Just Now Sec.gov Show details

Lexington, MA (February 25, 2021)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the year ended December 31, 2020, and provided an update on its product pipeline. “As we enter 2021, Concert is now a Phase 3 company, moving our lead drug candidate, CTP-543, towards a new drug application and

Category: Contact NumberShow more

Concert Pharmaceuticals : Mizuho Adjusts Price Target on

6 hours ago Marketscreener.com Show details

Concert Pharmaceuticals : Mizuho Adjusts Price Target on Concert Pharmaceuticals to $9 From $13, Maintains Buy Rating

Category: Contact NumberShow more

Is Concert Stock a good investment? CNCE 2.76 0.01 (0

7 hours ago Macroaxis.com Show details

Concert Pharmaceutic is trading at 2.76 as of the 20th of October 2021, a -0.36 percent down since the beginning of the trading day. The stock's lowest day price was 2.75. Get the latest Concert Pharmaceutic detailed stock quotes, stock trade data, stock price info, and performance analysis, including Concert Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is concert pharmaceuticals inc?

Concert Pharmaceuticals Inc. Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders.

What did concert pharmaceuticals report for q2?

Will Concert Pharmaceuticals (CNCE) Report Negative Q2 Earnings? What You Should Know Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology.

How to contact amneal pharmaceuticals for medical information?

Amneal, Impax and/or Gemini Laboratories Products. Report adverse events, product quality complaints and for medical information inquiries in the United States. Call (877) 835-5472, option 1 or email [email protected]

Brand New Updated

Popular Brands

Costco
Cisco
Ccu
Cae